a-Bromo-gamma-butyrolactone
CAS: 5061-21-2
Rif. 3D-FB04489
25g | Prezzo su richiesta | |
50g | Prezzo su richiesta | |
100g | Prezzo su richiesta | |
250g | Prezzo su richiesta | |
500g | Prezzo su richiesta |
Informazioni sul prodotto
- 2-Bromo-4-hydroxybutyric acid-gamma-lactone
- (3R)-3-bromodihydrofuran-2(3H)-one
- (3S)-3-bromodihydrofuran-2(3H)-one
- 2(3H)-Furanone, 3-bromodihydro-
- 2-Bromo-4-Butanolide
- 2-Bromo-4-butyrolactone
- 2-Bromo-4-hydroxybutyric acid g-lactone
- 2-Bromo-4-hydroxybutyric acid gamma-lactone
- 2-Bromo-gamma-butyrolactone
- 2-Bromo-γ-butyrolactone
- Vedi altri sinonimi
- 3-Bromo-2-oxotetrahydrofuran
- 3-Bromo-4,5-dihydro-2(3H)-furanone
- 3-Bromodihydro-2(3H)-furanone
- 3-Bromooxolan-2-one
- 3-Bromotetrahydrofuran-2-one
- 3-bromodihydrofuran-2(3H)-one
- Butyric acid, 2-bromo-4-hydroxy-, γ-lactone
- Butyric acid, α-bromo-γ-hydroxy-, γ-lactone
- NSC 11726
- NSC 56959
- a-Bromo-γ-butyrolatone
- alfa-Bromo-gamma butyrolatone
- Α-Bromo-R-Butyrolactone
- α-Bromo-γ-butyrolactone
- α-Bromobutyric acid γ-lactone
a-Bromo-gamma-butyrolactone (BBAL) is a structural analog of gamma-hydroxybutyric acid, a drug used to treat narcolepsy and cataplexy. BBAL can be synthesized by reacting anhydrous sodium with a mixture of bromoacetic acid and acrylonitrile in the presence of potassium hydroxide. The reaction mechanism for this process is not fully understood but it is believed that a tautomerization may occur between the two possible structures: alpha and beta. This product has been shown to provide pain relief in animal models as well as improve symptoms of metabolic disorders such as diabetes mellitus type II.
Proprietà chimiche
Richiesta tecnica su: 3D-FB04489 a-Bromo-gamma-butyrolactone
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.